<!DOCTYPE html>
<html lang="en">
<head>
  
  
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    
    
    <link rel="canonical" href="https://jzpero.github.io/mednotes/Infectious%20Diseases/Antibiotics%20101/">
    <link rel="shortcut icon" href="../../img/favicon.ico">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=1.0, user-scalable=0" />
    <title>Antibiotics 101 - MedNotes</title>
    <link href="../../css/bootstrap-3.3.7.min.css" rel="stylesheet">
    <link href="../../css/font-awesome-4.7.0.css" rel="stylesheet">
    <link href="../../css/base.css" rel="stylesheet">
    <link rel="stylesheet" href="../../css/highlight.css">
    <!-- HTML5 shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!--[if lt IE 9]>
        <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
        <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->

    <script src="../../js/jquery-3.2.1.min.js"></script>
    <script src="../../js/bootstrap-3.3.7.min.js"></script>
    <script src="../../js/highlight.pack.js"></script>
    
    <base target="_top">
    <script>
      var base_url = '../..';
      var is_top_frame = false;
        
        var pageToc = [
          {title: "Antibiotics 101", url: "#_top", children: [
              {title: "Categories of Antibiotics", url: "#categories-of-antibiotics" },
              {title: "Pathogens", url: "#pathogens" },
          ]},
        ];

    </script>
    <script src="../../js/base.js"></script> 
</head>

<body>
<script>
if (is_top_frame) { $('body').addClass('wm-top-page'); }
</script>



<div class="container-fluid wm-page-content">
  <a name="_top"></a>
    

    
    
      
    

  <div class="row wm-article-nav-buttons" role="navigation" aria-label="navigation">
    
    <div class="wm-article-nav pull-right">
      <a href="../Antimicrobial%20Resistant%20Gram-Negative%20Infections/" class="btn btn-xs btn-default pull-right">
        Next
        <i class="fa fa-chevron-right" aria-hidden="true"></i>
      </a>
      <a href="../Antimicrobial%20Resistant%20Gram-Negative%20Infections/" class="btn btn-xs btn-link">
        Antimicrobial Resistant Gram-Negative Infections
      </a>
    </div>
    
    <div class="wm-article-nav">
      <a href="../Actinomyces/" class="btn btn-xs btn-default pull-left">
        <i class="fa fa-chevron-left" aria-hidden="true"></i>
        Previous</a><a href="../Actinomyces/" class="btn btn-xs btn-link">
        Actinomyces
      </a>
    </div>
    
  </div>

    

    <h1 id="antibiotics-101">Antibiotics 101</h1>
<h2 id="categories-of-antibiotics">Categories of Antibiotics</h2>
<ul>
<li>beta-lactams<ul>
<li>penicillins</li>
<li>cephalosporins</li>
<li>monobactams</li>
<li>carbapenems</li>
</ul>
</li>
<li>aminoglycosides</li>
<li>glycopeptides/lipoglycopeptides</li>
<li>macrolides</li>
<li>clindamycin</li>
<li>tetracyclines</li>
<li>fluoroquinolones</li>
</ul>
<h3 id="beta-lactams">Beta-Lactams</h3>
<p>Common central structure with a beta lactam ring and a thiazolidine ring (penicillins and carbapenems) or a dihydrothiazine ring (cephalosporins).
All bind to and inhibit PBPs, enzymes important for cross-linking bacterial cell wall peptidoglycans. Prevents cross linkage of the cell wall peptigoglycans, leading to loss of bacterial cell wall integrity. All require active bacterial growth for bacteriocidal action.</p>
<h4 id="penicillins">Penicillins</h4>
<table>
<thead>
<tr>
<th>Penicillin Class</th>
<th>Examples</th>
<th>Description</th>
</tr>
</thead>
<tbody>
<tr>
<td>Natural penicillins</td>
<td>penicillin G</td>
<td>Narrow spectrum, short half lives, mostly IV or IM, well-distributed through the body.</td>
</tr>
<tr>
<td>Aminopenicillins</td>
<td>amoxicillin, ampicillin</td>
<td>Broader spectrum then natural pcns. Can be given orally due to modifications that protect against stomach acids. Higher peak levels means longer dosing interval.</td>
</tr>
<tr>
<td>Penicillinase-resistant penicillins</td>
<td>oxacillin, nafcillin, cloxacillin, dicloxacillin</td>
<td>Hepatic clearance, but same short half life means q4h dosing. Very narrow spectrum.</td>
</tr>
<tr>
<td>Ureidopenicillins</td>
<td>piperacillin</td>
<td>Intrinsic resistance to many beta-lactamases. Short half life. Covers GN, Pseudomonas, MSSA.</td>
</tr>
</tbody>
</table>
<h4 id="cephalosporins">Cephalosporins</h4>
<table>
<thead>
<tr>
<th>Generation</th>
<th>Examples</th>
<th>Description</th>
</tr>
</thead>
<tbody>
<tr>
<td>I</td>
<td>cefazolin, cephalexin, cefadroxil</td>
<td>Predominantly effective against Gram-positive cocci. Frequently used for MSSA/GAS soft tissue infections, surgical prophylaxis, impetigo.</td>
</tr>
<tr>
<td>II</td>
<td>cefuroxime, cefprozil</td>
<td>Increased activity against aerobics and anaerobic GNB. Effective against MSSA and non-enterococcal Strep.</td>
</tr>
<tr>
<td>III</td>
<td>ceftriaxone, ceftazidime, cefotaxime, cefixime</td>
<td>Enhanced GNB activity, does not cover SPICE organisms. Ceftazidime covers <em>Pseudomonas</em>.</td>
</tr>
<tr>
<td>IV</td>
<td>cefepime, cefpirome</td>
<td>Broadest spectrum of activity. Effective against GPB and GNB. Zwitterionic properties allow excellent penetration of body cavities. Resistant to most beta-lactamases. Cefepime covers Pseudomonas.</td>
</tr>
<tr>
<td>V</td>
<td>ceftaroline</td>
<td>Anti-MRSA. Superior in CAP. Excellent body space penetration.</td>
</tr>
</tbody>
</table>
<h2 id="pathogens">Pathogens</h2>
<h3 id="mssa">MSSA</h3>
<p>Oral options</p>
<ul>
<li>Cephalosporin<ul>
<li>Cephalexin (Keflex; TID to QID dosing)</li>
<li>Cefadroxil (advantage = BID dosing)</li>
</ul>
</li>
</ul>
<p>IV options</p>
<ul>
<li>Cephalosporin<ul>
<li>Cefazolin</li>
<li>Cloxacillin</li>
</ul>
</li>
</ul>
<h3 id="mrsa">MRSA</h3>
<ul>
<li>Oral options</li>
<li>Clindamycin</li>
<li>TMP-SMX</li>
<li>Doxycycline</li>
<li>Linezolid</li>
<li>IV options</li>
<li>Vancomycin</li>
<li>Daptomycin (not for respiratory infections)</li>
<li>Linezolid</li>
<li>Clindamycin</li>
</ul>
<h3 id="pseudomonas">Pseudomonas</h3>
<ul>
<li>Cephalosporins</li>
<li>Ceftazidime (III)</li>
<li>Cefepime (IV)</li>
<li>Carbapenems</li>
<li>Doripenem &gt; meropenem &gt; imipenem</li>
<li>Penicillins</li>
<li>Pip-Tazo</li>
<li>Fluoroquinolones</li>
<li>Ciprofloxacin (usually the only appropriate PO option)</li>
<li>Levofloxacin (respiratory coverage only)</li>
</ul>

  <br>
    

    
    
      
    

  <div class="row wm-article-nav-buttons" role="navigation" aria-label="navigation">
    
    <div class="wm-article-nav pull-right">
      <a href="../Antimicrobial%20Resistant%20Gram-Negative%20Infections/" class="btn btn-xs btn-default pull-right">
        Next
        <i class="fa fa-chevron-right" aria-hidden="true"></i>
      </a>
      <a href="../Antimicrobial%20Resistant%20Gram-Negative%20Infections/" class="btn btn-xs btn-link">
        Antimicrobial Resistant Gram-Negative Infections
      </a>
    </div>
    
    <div class="wm-article-nav">
      <a href="../Actinomyces/" class="btn btn-xs btn-default pull-left">
        <i class="fa fa-chevron-left" aria-hidden="true"></i>
        Previous</a><a href="../Actinomyces/" class="btn btn-xs btn-link">
        Actinomyces
      </a>
    </div>
    
  </div>

    <br>
</div>

<footer class="container-fluid wm-page-content">
  <p>Documentation built with <a href="https://www.mkdocs.org/">MkDocs</a> using <a href="https://github.com/gristlabs/mkdocs-windmill">Windmill</a> theme by Grist Labs.</p>
</footer>

</body>
</html>